Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.5 USD | 0.00% | 0.00% | +13.28% |
Financials (USD)
Sales 2022 | 66.15M | Sales 2023 | 62.66M | Capitalization | 67.98M |
---|---|---|---|---|---|
Net income 2022 | 5M | Net income 2023 | - | EV / Sales 2022 | 1.2 x |
Net Debt 2022 | 16.54M | Net Debt 2023 | 11.33M | EV / Sales 2023 | 1.27 x |
P/E ratio 2022 |
11.9
x | P/E ratio 2023 |
81.7
x | Employees | 113 |
Yield 2022 |
1.43% | Yield 2023 |
0.66% | Free-Float | 55.92% |
1 month | -9.38% | ||
3 months | +0.69% | ||
6 months | +20.83% | ||
Current year | +13.28% |
Managers | Title | Age | Since |
---|---|---|---|
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 03-07-31 |
Charles C Kirk
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 22-05-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 87 | 14-12-31 | |
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 03-07-31 |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 72.5 | 0.00% | 332 |
Delayed Quote OTC Markets, May 07, 2024 at 10:20 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.28% | 64.85M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.17% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- BIOQ Stock